DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
- $697.34 - $1206.98
- Product name: DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
- CAS: 204318-14-9
- MF: C65H92N14O18S2
- MW: 1421.65
- EINECS:
- MDL Number:MFCD08459383
- Synonyms:DOTA-[TYR3]-OCTREOTIDE;DOTATOC;DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7);DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7);[DOTA-DPHE1, TYR3]OCTREOTIDE;DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL;EDOTREOTIDE;4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND)
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
Package
- 1MG
- 5MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0005192
- Product descriptionEDOTREOTIDE 95.00%
- Packaging1MG
- Price$697.34
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0005192
- Product descriptionEDOTREOTIDE 95.00%
- Packaging5MG
- Price$1206.98
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | API0005192 | EDOTREOTIDE 95.00% | 1MG | $697.34 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0005192 | EDOTREOTIDE 95.00% | 5MG | $1206.98 | 2021-12-16 | Buy |
Properties
alpha :22D -14.75° (c = 0.52 in 95% acetic acid)
Boiling point :1723.7±65.0 °C(Predicted)
Density :1.46±0.1 g/cm3(Predicted)
pka :1.83±0.10(Predicted)
form :Solid
color :White to off-white
Sequence :DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)
Boiling point :1723.7±65.0 °C(Predicted)
Density :1.46±0.1 g/cm3(Predicted)
pka :1.83±0.10(Predicted)
form :Solid
color :White to off-white
Sequence :DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|